Current position:Home >Product >
N,N'-Bis(2,3-dihydroxypropyl)-2-(hydroxymethyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide
N,N'-Bis(2,3-dihydroxypropyl)-2-(hydroxymethyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide(196309-19-0)
- Name: N,N'-Bis(2,3-dihydroxypropyl)-2-(hydroxymethyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide
- Synonyms:Y2Z89O65DS;Iohexol impurity I [EP];UNII-Y2Z89O65DS;196309-19-0;N,N'-Bis(2,3-dihydroxypropyl)-2-(hydroxymethyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide;(+/-)-N,N'-Bis(2,3-dihydroxypropyl)-2-(hydroxymethyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide;2H-1,4-Benzoxazine-6,8-dicarboxamide, N6,N8-bis(2,3-dihydroxypropyl)-3,4-dihydro-2-(hydroxymethyl)-5,7-diiodo-;IOHEXOL IMPURITY I [EP IMPURITY];Q27294192;6-N,8-N-bis(2,3-dihydroxypropyl)-2-(hydroxymethyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide
- Molecular Formula:C17H23I2N3O8
- Molecular Weight:651.2
- CAS Registry Number:196309-19-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.196309-19-0 Iohexol EP Impurity I
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 17415-78-0/N-[3-(2-amino-4-methyl-6-oxo-1H-pyrimidin-5-yl)propyl]-N-(3-aminopropyl)-4-methylbenzenesulfonamide;2,4,6-trinitrophenol
- 630423-21-1/Isoquinoline, 1-chloro-5-(trifluoromethoxy)-
- 71309-96-1/6,19-Ditert-butyl-3,16-dioxa-1,6,14,19-tetrazatricyclo[20.4.0.09,14]hexacosane
- 247912-76-1/Desethyl chloroquine diphosphate
- 1451210-48-2/8-Hydroxy-PIPAT oxalate
- 1217197-58-4/1451210-48-2
- 1415562-49-0/N-(5-iodo-3-nitro-6-(4-nitrophenethoxy)pyridin-2-yl)acetamide
- 3283-70-3/(2Z)-But-2-enedioic acid--N-benzyl-2-hydrazinyl-N-methylethan-1-amine (1/1)
- 1820711-54-3/6-(1-Naphthylamino)-1,4-benzodioxane
- 1636180-98-7/Tarloxotinib bromide
- 1000343-31-6/5-Bromo-2-(2-chloroethyl)-1,3-dinitrobenzene
- 856045-95-9/2-(1-Chlorocyclopropyl)-1-(2-chlorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl) propanol
- 883544-09-0/1-(2-Allyl-4-methyl-phenoxy)-3-piperazin-1-yl-propan-2-ol
- 885956-74-1/3-Fluoro-5-trifluoromethyl-benzamidine
- 1184919-47-8/N4-cyclopentyl-N2,6-dimethylpyrimidine-2,4,5-triamine
- 1203680-76-5/3-[(4-Chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide
- 955036-17-6/1-Benzyl-2-(fluoromethyl)piperidine
- 2070931-57-4/7-(4-Fluoro-2-methoxyphenyl)-6-methyl-N-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) thieno (3,2-d)pyrimidin-2-amine
- 186599-47-3/2-(Heptadecafluorooctyl)ethylmethylbis(dimethylamino)silane
- 196309-19-0/N,N'-Bis(2,3-dihydroxypropyl)-2-(hydroxymethyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide
- 13800-21-0/(2Z)-But-2-enedioic acid--1-(2-hydrazinylethyl)pyrrolidine (1/1)
- 1220027-01-9/3-(2-Thienyl)-1H-indole-2-carboxylic acid
- 1378842-38-6/2-(Fluoromethyl)benzoic acid
- 1221792-05-7/Ethyl 3-cyano-4,6-dimethyl-2-pyridinecarboxylate
- 1256819-97-2/5-(Piperidin-4-yl)-2-(trifluoromethyl)pyridine
- 1354705-44-4/1-(Difluoromethyl)-4-iodo-5-methyl-1H-pyrazole
- 869949-97-3/7-(Thiophen-2-yl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
- 1473422-93-3/7-Oxaspiro[3.5]nonan-1-one
- 1217602-85-1/(2R,3R)-3-((tert-Butoxycarbonyl)amino)-2-hydroxy-3-(naphthalen-2-yl)propanoic acid
- 887304-84-9/(2S,5S)-5-Methyl-2-(naphthalen-1-yl)-5-phenyl-1,3-dioxolan-4-one